Perikarderguß während der Therapie eines Morbus Crohn mit 5-Aminosalicylsäure

TL;DRAbstract

A 22-year-old woman with Crohn's disease was treated with 5-aminosalicylic acid (Claversal), four times 500 mg daily, because of increased inflammatory activity. Retrosternal pain set in after two weeks; in another two weeks a moderately enlarged heart was noted on the chest X-ray and pericardial effusion diagnosed echocardiographically. After stopping the medication the pericardial effusion resolved without further treatment. Immunoserology failed to demonstrate autoantibodies, but a repeat lymphocyte stimulation test was positive. There is a possible causal relationship between 5-aminosalicylic acid medication and the pericardial effusion, although the pathogenetic mechanisms is not known.

Chat with Paper

AI Agents for this Paper